Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1998;83:772-773

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaley, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaley, G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*NITRIC OXIDE
(Circulation Research. 1998;83:772-773.)
© 1998 American Heart Association, Inc.


Editorial

Novel Vasodilator Released by Retinal Tissue

Gabor Kaley

Correspondence to Gabor Kaley, PhD, Department of Physiology, New York Medical College, Valhalla, NY 10595. E-mail gabor_kaley@nymc.edu


Key Words: retina-derived relaxing factor • vasodilation • vascular regulation.

Aseries of classical experiments within the past 20 years, all of which used the incubation of donor tissues with detector blood vessels, have yielded a rich trove of vasoactive principles, culminating in the discovery of the physiologically relevant vasodilator mediators prostacyclin1 and nitric oxide (NO).2 In a like manner, Delaey and Van de Voorde3 report in this issue of Circulation Research, evidence for the existence of yet another tissue-derived vasoactive factor that may have broad implications for vascular research.

The salient finding of the study presented by Delaey and Van de Voorde3 is that adherent retinal tissue, but not a similar-sized piece of choroidal tissue, of a variety of species exerts an inhibitory effect on the contractile tone of isolated, endothelium-intact, or denuded bovine retinal arteries. Moreover, contractions induced by a variety of agents, ie, U-46619, serotonin, and endothelin-1, were also blocked in the presence of retinal tissue. Collectively, these experiments can be interpreted to mean that retinal tissue releases a diffusible vasorelaxant that not only relaxes the retinal artery but also other smooth muscle preparations such as rat mesenteric and renal arteries and rat main bronchi, as demonstrated by Delaey and Van de Voorde. Also shown is that incubation of retinal tissue yields a solution that relaxes isolated bovine retinal arteries, further confirming the involvement of a diffusible chemical substance.

Previous studies by other investigators have already shown that prostaglandin (PG) E1 is capable of causing dilation of pig retinal arterioles and that administration of indomethacin into the . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
IOVSHome page
G. Weigert, F. Berisha, H. Resch, K. Karl, L. Schmetterer, and G. Garhofer
Effect of Unspecific Inhibition of Cyclooxygenase by Indomethacin on Retinal and Choroidal Blood Flow
Invest. Ophthalmol. Vis. Sci., March 1, 2008; 49(3): 1065 - 1070.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. Boussery, C. Delaey, and J. Van de Voorde
The Vasorelaxing Effect of CGRP and Natriuretic Peptides in Isolated Bovine Retinal Arteries
Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1420 - 1427.
[Abstract] [Full Text] [PDF]